The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome
Interview with Mina S. Ally, BSc, MBBS, author of The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"JAMA Dermatology Author Interviews","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/jamadermatologyauthorinterviews\/JAMA_Dermatology_2014-03-12_Author_Interview.mp3?dest-id=422061","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202109\/4e1e7e-cbc0-d822-cf2203_800.jpg"},"title":"The Use of Vismodegib to Shrink Keratocystic Odontogenic Tumors in Patients With Basal Cell Nevus Syndrome","link":"javascript:;","id":"item-5535736"}]